Immanuel Thangaraj

Immanuel Thangaraj has a diverse work experience spanning various roles and companies. Immanuel is the Co-Founder and CEO of Jurna, a position they have held since 2021. Prior to that, they were the Co-Founder and Chairman of DEFENDER BIO in 2020 and Synovetin OA® in 2019. Immanuel also co-founded Olympic Ophthalmics in 2017 and Serene, LLC in 2010, where they served as Chairman in both companies.

In addition to their entrepreneurial ventures, Immanuel has held advisory and board positions. Immanuel was a Member of the College Advisory Council at the University of Chicago since 2015 and a Member of the Board of Advisors at Polsky Center at the University of Chicago since 2004.

Immanuel Thangaraj also has investment experience, as they served as a Board Member and Lead Investor at Acura Pharmaceuticals, Inc, a drug delivery company, since 2002.

Furthermore, they have a background in venture capital, having founded Park Lane Ventures in 2014 and serving as the Founder and Managing Director. Immanuel also served as a Managing Director at EW Healthcare Partners from 1996 to 2019, where they were responsible for Legacy Funds.

Overall, Immanuel Thangaraj's work experience showcases their entrepreneurial spirit, involvement in advisory and board positions, investment expertise, and experience in venture capital.

Immanuel Thangaraj's education history begins with their enrollment at Amboy High School, where they completed their high school education in 1988. Following this, they pursued a Bachelor's Degree at the University of Chicago, completing their undergraduate studies in an unspecified field of study in 1992. Later, they went on to earn a Master of Business Administration (M.B.A.) from The University of Chicago Booth School of Business in 1993.